MedSci在全国的讲座汇总

2011-11-10 MedSci原创 MedSci原创

MedSci在全国的讲座 MedSci“临床科研中国行”全国巡回讲座--北京第306医院 MedSci在“2011细胞治疗技术研讨会”上精彩讲座 MedSci“临床科研中国行”全国巡回讲座--北京肿瘤医院 MedSci“临床科研中国行”全国巡回讲座--北京友谊医院 MedSci“临床科研中国行”全国巡回讲座--海军总医院 MedSci“临床科研中国行”全国巡回讲座--空军总医

MedSci在全国的讲座

  • MedSci“临床科研中国行”全国巡回讲座--北京第306医院
  • MedSci在“2011细胞治疗技术研讨会”上精彩讲座
  • MedSci“临床科研中国行”全国巡回讲座--北京肿瘤医院
  • MedSci“临床科研中国行”全国巡回讲座--北京友谊医院
  • MedSci“临床科研中国行”全国巡回讲座--海军总医院
  • MedSci“临床科研中国行”全国巡回讲座--空军总医院
  • MedSci首席科学家陈鹂博士在“2011干细胞技术临床转化应用讲座与培训”上精彩讲座
  • MedSci“临床科研中国行”全国巡回讲座(上海东方医院)圆满落幕
  • MedSci“临床科研中国行”全国巡回讲座(杭州站)圆满落幕
  • MedSci参加第三届中英癌症生物学前沿研讨会
  • 第一届国际医学影像临床应用与学术论著发表策略研讨会圆满落下帷幕
  • 快讯:2011年国际临床医学SCI论文写作与表发策略研讨会圆满成功
  • 2011年国际临床医学SCI论文写作与表发策略研讨会
  • MedSci“临床科研中国行”全国巡回讲座(武汉站)圆满落幕
  • MedSci“临床科研中国行”全国巡回讲座(南京军区南京总医院)圆满落幕
  • MedSci参加“中华医学会肾脏病分会2010学术年会”
  • MedSci参加“2010中国-FIGO妇科肿瘤学术大会”
  • MedSci“肿瘤研究和SCI论文设计与发表”讲座圆满落幕
  • MedSci“临床科研中国行”全国巡回讲座(四川、重庆站)圆满落幕
  • MedSci“临床科研中国行”全国巡回讲座(四川成都站)圆满落幕
  • MedSci“临床科研中国行”全国巡回讲座(重庆站)圆满落幕
  • MedSci“临床科研中国行”全国巡回讲座(四川泸州站)圆满落幕
  • MedSci“临床科研中国行”全国巡回讲座(北京站)圆满成功
  • MedSci科室讲座——上海东方医院骨科
  • MedSci在积水潭医院成功举办讲座
  • MedSci在北京大学人民医院,解放军总院等举办多场巡回讲座
  • MedSci医学SCI论文发表支持讲座(武汉站)取得圆满成功
  • MedSci在解放军总院(301)成功举办讲座
  • MedSci科室讲座——浙大附一心血管内科
  • MedSci成功在天津主办SCI论文写作讲座
  • 版权声明:
    本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
    在此留言
    评论区 (5)
    #插入话题
    1. [GetPortalCommentsPageByObjectIdResponse(id=37399, encodeId=ba343e39989, content=You've got it in one. Codnlu't have put it better., beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=mika, createdTime=Sun Sep 27 07:43:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4919, encodeId=b6be4919b7, content=This is an article that makes you think "never tohguht of that!", beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=solomon, createdTime=Thu Nov 08 06:38:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3920, encodeId=776e392006, content=These pieces really set a satnardd in the industry., beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=94.132.216.2, createdTime=Tue Jan 10 13:42:00 CST 2012, time=2012-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3905, encodeId=0a3b39059d, content=No quseiotn this is the place to get this info, thanks y'all., beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=60.251.239.251, createdTime=Sat Jan 07 21:07:00 CST 2012, time=2012-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605624, encodeId=faba1605624b6, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Nov 12 01:16:00 CST 2011, time=2011-11-12, status=1, ipAttribution=)]
      2015-09-27 mika

      You've got it in one. Codnlu't have put it better.

      0

    2. [GetPortalCommentsPageByObjectIdResponse(id=37399, encodeId=ba343e39989, content=You've got it in one. Codnlu't have put it better., beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=mika, createdTime=Sun Sep 27 07:43:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4919, encodeId=b6be4919b7, content=This is an article that makes you think "never tohguht of that!", beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=solomon, createdTime=Thu Nov 08 06:38:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3920, encodeId=776e392006, content=These pieces really set a satnardd in the industry., beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=94.132.216.2, createdTime=Tue Jan 10 13:42:00 CST 2012, time=2012-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3905, encodeId=0a3b39059d, content=No quseiotn this is the place to get this info, thanks y'all., beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=60.251.239.251, createdTime=Sat Jan 07 21:07:00 CST 2012, time=2012-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605624, encodeId=faba1605624b6, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Nov 12 01:16:00 CST 2011, time=2011-11-12, status=1, ipAttribution=)]
      2012-11-08 solomon

      This is an article that makes you think "never tohguht of that!"

      0

    3. [GetPortalCommentsPageByObjectIdResponse(id=37399, encodeId=ba343e39989, content=You've got it in one. Codnlu't have put it better., beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=mika, createdTime=Sun Sep 27 07:43:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4919, encodeId=b6be4919b7, content=This is an article that makes you think "never tohguht of that!", beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=solomon, createdTime=Thu Nov 08 06:38:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3920, encodeId=776e392006, content=These pieces really set a satnardd in the industry., beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=94.132.216.2, createdTime=Tue Jan 10 13:42:00 CST 2012, time=2012-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3905, encodeId=0a3b39059d, content=No quseiotn this is the place to get this info, thanks y'all., beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=60.251.239.251, createdTime=Sat Jan 07 21:07:00 CST 2012, time=2012-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605624, encodeId=faba1605624b6, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Nov 12 01:16:00 CST 2011, time=2011-11-12, status=1, ipAttribution=)]
      2012-01-10 94.132.216.2

      These pieces really set a satnardd in the industry.

      0

    4. [GetPortalCommentsPageByObjectIdResponse(id=37399, encodeId=ba343e39989, content=You've got it in one. Codnlu't have put it better., beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=mika, createdTime=Sun Sep 27 07:43:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4919, encodeId=b6be4919b7, content=This is an article that makes you think "never tohguht of that!", beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=solomon, createdTime=Thu Nov 08 06:38:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3920, encodeId=776e392006, content=These pieces really set a satnardd in the industry., beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=94.132.216.2, createdTime=Tue Jan 10 13:42:00 CST 2012, time=2012-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3905, encodeId=0a3b39059d, content=No quseiotn this is the place to get this info, thanks y'all., beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=60.251.239.251, createdTime=Sat Jan 07 21:07:00 CST 2012, time=2012-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605624, encodeId=faba1605624b6, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Nov 12 01:16:00 CST 2011, time=2011-11-12, status=1, ipAttribution=)]
      2012-01-07 60.251.239.251

      No quseiotn this is the place to get this info, thanks y'all.

      0

    5. [GetPortalCommentsPageByObjectIdResponse(id=37399, encodeId=ba343e39989, content=You've got it in one. Codnlu't have put it better., beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=mika, createdTime=Sun Sep 27 07:43:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4919, encodeId=b6be4919b7, content=This is an article that makes you think "never tohguht of that!", beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=solomon, createdTime=Thu Nov 08 06:38:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3920, encodeId=776e392006, content=These pieces really set a satnardd in the industry., beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=94.132.216.2, createdTime=Tue Jan 10 13:42:00 CST 2012, time=2012-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3905, encodeId=0a3b39059d, content=No quseiotn this is the place to get this info, thanks y'all., beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=60.251.239.251, createdTime=Sat Jan 07 21:07:00 CST 2012, time=2012-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605624, encodeId=faba1605624b6, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Nov 12 01:16:00 CST 2011, time=2011-11-12, status=1, ipAttribution=)]

    相关资讯

    MedSci在天津**中心医院成功举办讲座

        MedSci“临床科研中国行”全国巡回讲座,此次讲座,主要有三站,北京第306医院,天津医科大学和天津第一中心医院,分别于2011年10月24日-26日成功主办,每次讲座均吸引超过400人次,取得了良好的反响。     本次讲座主题包括国家自然科学基金申请与写作技巧,经常易犯的问题,以及明年国家自然科学基金的可能趋势和特点,如何

    MedSci“临床科研中国行”全国巡回讲座--天津医科大学

    MedSci“临床科研中国行”全国巡回讲座--天津医科大学于2011年10月25日成功主办,本次讲座主题包括国家自然科学基金申请与写作技巧,经常易犯的问题,以及明年国家自然科学基金的可能趋势和特点,如何将临床资料转化成SCI文章,SCI论文写作技巧,以及如何从REVIEWER角度看SCI文章。由MedSci首席科学家陈鹂博士和学术编辑屠广德博士分别主讲。 与MedSci历次讲座一样,本次讲座吸引

    MedSci喜获商标注册证

        为了防止虚假假冒等行为,我们公司特意申请了商标注册证。MedSci成功获得在翻译,出版领域的商标注册证。下图为国家行政工商管理总局的商标局颁发的商标注册证。  

    公告:2011年8月31日晚6:00到2011年9月1日下午3:00期间邮件无法正常接收

    尊敬的广大会员:     由于MedSci邮件服务器故障,2011年8月31日晚6:00到2011年9月1日下午3:00期间邮件无法正常接收,目前已顺利修复。如果您在此期间,给MedSci发过邮件,或发送过文章进行评估的,请重新再发送一遍,或来电与我们客服人员确认,文章或信件是否收到。在此期间的,编辑工作正常开展,不必担心。    

    MedSci“临床科研中国行”全国巡回讲座--北京第306医院

        MedSci“临床科研中国行”全国巡回讲座--北京中国人民解放军第306医院于2011年10月24日成功主办,本次讲座主题包括如何将临床资料转化成SCI文章,SCI论文写作技巧,以及如何从REVIEWER角度看SCI文章。由MedSci首席科学家陈鹂博士和学术编辑屠广德博士分别主讲。     与MedSci历次讲座一样,本次讲座